UT7-TPO
Export
AML
Cell Type:
Myeloid (unspec.)
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
R
T-024
1e6
70%
Plasmid (general)
µg
100 µl
I/II/2b
Citations
Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL
Categories:
Transfection
Authors:
Kozuma Y, Kojima H, Yuki S, Suzuki H, Nagasawa T
In:
J Thromb Haemost (2007) 5(6): 1274-82
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
Categories:
Transfection
Authors:
Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL
In:
PLoS Med (2006) 3(7): e270
Molecular and Functional Analyses of a Human Parvovirus B19 Infectious Clone Demonstrates Essential Roles for NS1, VP1, and the 11-Kilodalton Protein in Virus Replication and Infectivity
Categories:
Transfection
Authors:
Zhi N, Mills IP, Lu J, Wong S, Filippone C, Brown KE
In:
J Virol (2006) 80(12): 5941-5950